▮ Slide Shows

▮ Entertainment

Top Stories
Game of Thrones
▮ Music news
- Pop
- Rock
- Classic Rock
- Rap/Hip-Hop
- Country
- Alternative
- Oldies
- All Genre

▮ Content Licensing

▮ Premium NEW

▮ More

Wall Street Events

FedEx Q4 22 Earnings Conference Call At 5:00 PM ET

By RTTNews Staff Writer ✉ | Published: 6/23/2022 6:31 AM ET

FedEx Corporation (FDX) will host a conference call at 5:00 PM ET on June 23, 2022, to discuss Q4 22 earnings results.

To access the live webcast, log on to https://investors.fedex.com/news-and-events/upcoming-events/default.aspx

For comments and feedback contact: editorial@rttnews.com

Biotech Stocks Facing FDA Decision In February 2023

Biotech Stocks Facing FDA Decision In February 2023

Biotech stocks Facing FDA Decision in January 2023

Biotech stocks Facing FDA Decision in January 2023

Biotech Stocks Facing FDA Decision In December 2022

Biotech Stocks Facing FDA Decision In December 2022

Latest Updates on COVID-19

Covid-19 Remains An International Emergency: WHO

FDA Advisors Propose To Replace Primary COVID Shots With New Bivalent Shots

U.S. Covid Metrics Signal Ease In Pandemic

US Covid Deaths Rise By 78% In 2 Weeks

78% Increase In US Covid Deaths In A Fortnight

Read More

COVID-19: Drugs in Development

RELATED NEWS

FedEx To Reduce More Than 10% Of Its Officers And Directors

FedEx Corporation Q2 Profit Decreases, but beats estimates

Follow RTT

Editor's Pick
Most Read
Most Emailed

Google Unveils Conversational AI Service Bard

DuPont Q4 Results Miss Estimates; Boosts Dividend 9%

Boeing To Cut About 2000 Finance, HR Jobs In 2023

Fresh Ideation Recalls Sandwiches And Other Products

FSIS Warns Against Ready-To-Eat Stuffed Chicken Product

FSIS Warns Against Wegmans Chicken Korma With Basmati Turmeric Rice

Daiso Recalls Certain Prepackaged Snacks

Children's Robes, Pajamas Recalled On Burn Risks

China's Xpeng Launches Two Smart EVs For Europe

Shop Me Ca Recalls Diep Bao Cream For Lead Concerns

IBSA Pharma Recalls TIROSINT-SOL Oral Solution

FDA Approves GSK's Drug For Anemia Caused By CKD For Adults On Dialysis

CVS Health Nears Deal To Acquire Oak Street Health For About $10.5 Bln : Report

Kyndryl In Deal To Manage Stellantis' Core IT Infrastructure

FirstEnergy To Sell Addl 30% Stake In FirstEnergy Transmission To Brookfield

Regeneron Pharmaceuticals Q4 Profit Declines

Personalis, Moderna Continue Partnership On Personalized Cancer Vaccine Program

Canada Goose Drops 14% On Lower Profit, Decreased Outlook

Gracell Biotechnologies: FDA Clears IND Application Of GC012F

INOVIO Pharma Announces Positive Results From Phase 1b Clinical Trial Evaluating INO-4201

FDA Approves GSK's Drug For Anemia Caused By CKD For Adults On Dialysis

Twist Bioscience Corp Q1 Loss decreases, beats estimates

Merck's KEYTRUDA Plus Chemotherapy Meets Primary Goal As First-Line Therapy In Endometrial Carcinoma

AstraZeneca, Amgen's Tezspire Pre-filled Pen Receives FDA Approval In US For Asthma

Take-Two Interactive Software Inc Q3 Earnings Summary

Crown Holdings Inc. Q4 Earnings Summary

Camden Property Trust Q4 Profit Falls

Aptiv Q4 Profit Up, Above Estimates - Update

Genworth Financial Inc. Q4 Profit Increases, beats estimates

ON Semiconductor Guides Q1 Well Below Estimates; Approves $3 Bln Share Buyback - Update

Bed Bath & Beyond Plans To Raise About $1 Bln To Avoid Bankruptcy

Black Hills Corp Q4 Profit misses estimates

Timken Guides FY23 In Line With View; Q4 Adj. EPS Tops Estimates

Snap-On Inc. Reveals Increase In Q4 Bottom Line, Beats estimates

Deutsche Bank Q4 Earnings Soar

Guardant Health Says Illumina Has No Basis For Challenging Ownership Of Its Patents